ENAapplication/xmlprimaryOK200GenomicsSCAID 187Scientific Center for Anti-infectious Drugs (SCAID)https://www.ebi.ac.uk/ena/browser/view/PRJNA291131Mycobacterium tuberculosisMycobacterium tuberculosis strain SCAID 187 was isolated from sputum of patient with MDR-TB. participated in 2nd B phase of clinical trials of new drug FS-1. The sputum from patient was collected before the first dose intake (in screening stage). Drug Susceptibility Test on solid and liquid media showed resistance to the 1st-line anti-TB drugs and to some anti-TB-drugs from the 2nd line. This strain was sequenced for studying reversion of sensitivity which was discovered during clinical trials and confirmed in experiment on guinea pigs.pathogen:prioritypathogen:bacteriumpathogenxref:EuropePMC:PMC4645197bacteriaENAfalseMycobacterium tuberculosis strain:SCAID 187Mycobacterium tuberculosis strain:SCAID 187 Genome sequencing and assembly2025-09-242015-07-29PRJNA2911311773